阿尔茨海默病中的C/EBPβ:病理机制的整合性调节器
Xiaoting Luo1, Junyi Liang1, Xue Lei2
1Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Brain research bulletin
|January 9, 2025
概括
转录因子C/EBPβ在阿尔茨海默病 (AD) 进展中起着关键作用,影响神经炎症和蛋白质聚合. 准C/EBPβ为新型AD治疗提供了一个有希望的途径.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,发病率越来越高.
- 目前的AD治疗效果有限,需要对疾病机制有更深入的了解.
- 转录因子C/EBPβ越来越多地被认为是它在AD病变发生过程中的作用.
研究的目的:
- 系统地审查C/EBPβ在阿尔茨海默病中的多方面的作用.
- 探索C/EBPβ在神经炎症,粉样β处理,病理和脂质代谢中的参与.
- 批判性地评估针对C/EBPβ的治疗策略.
主要方法:
- 文学综述综合了关于C/EBPβ和AD的当前研究.
- 分析C/EBPβ的翻译后修饰及其对AD路径的影响.
- 评估C/EBPβ作为治疗点的潜力.
主要成果:
- C/EBPβ是AD中关键病理过程的关键调节者.
- 它影响神经炎症,粉样β (Aβ) 斑块形成和陶酸化.
- 在AD中脂质代谢的失调也与C/EBPβ活性有关.
结论:
- C/EBPβ是阿尔茨海默氏症病变的多个方面的一个核心参与者.
- 了解C/EBPβ的调节机制对于开发有效的AD治疗至关重要.
- 准C/EBPβ为未来的治疗干预提供了重大机遇和挑战.
更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
94.0K
相关概念视频
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
Allosteric Regulation
57.6K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.6K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Role of Neurotransmitters in Memory
420
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
420
